Outlook Therapeutics Q3 2026 Earnings Preview (NASDAQ:OTLK)
· seekingalpha.com
Outlook Therapeutics (OTLK) Q3 earnings Aug 14: EPS -$0.07, revenue $0.97M, estimate revisions & beat history.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...